Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus (LES-HYDROXY)

Toulouse University Hospital

Status: Completed

Conditions: Lupus Erythematosus

Treatments: Other: The Morisky Medication Adherence Scale

Study type: Observational

Funder types: Other

Identifiers

NCT06161363

RC31/23/0473

Details and patient eligibility

About

The project focuses on non-compliance in patients with systemic lupus erythematosus taking Plaquenil. More than half of patients with chronic illness are not or only poorly compliant with their treatment and lupus is one of them.

The investigators want to use an already validated existing questionnaire in English, the Morisky Medication Adherence Scale 8 (MMAS 8). These results will make it possible, after a multivariate study with reference to the gold standard which is hydroxychloroquinemia, to see which exact questions in the questionnaire can be used in general medicine practices in order to detect less or non-compliant patients as early as possible.

Enrollment: 102 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Age >18 years

• Patient with systemic lupus erythematosus
• Treatment with PLAQUENIL for > 6 months with dosage of hydroxychloroquinemia planned during the consultation.

Trial design

102 participants in 1 patient group

The Morisky Medication Adherence Scale (MMAS-8)

Description:

The Morisky Medication Adherence Scale completed by the patients

Treatment:

Other: The Morisky Medication Adherence Scale